|
Diabetes, Vol 41, Issue 7 835-842, Copyright © 1992 by American Diabetes Association
Nutrition and somatomedin XXIX. Molecular regulation of IGFBP-1 in hepatocyte primary culture
BC Villafuerte, S Goldstein, DG Robertson, CI Pao, LJ Murphy and LS Phillips
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
The insulinlike growth factors (IGFs) circulate in association with
insulinlike growth factor binding proteins (IGFBPs) that modulate IGF
action, but mechanisms of IGFBP regulation are poorly understood. We
investigated the regulation of IGFBPs in primary cultures of rat
hepatocytes, measuring the appearance of export proteins by ligand blotting
after separation via SDS/PAGE, and evaluating mRNA with cDNA probes.
Northern blotting studies revealed that IGFBP-1 was expressed at high
levels in cultured hepatocytes, in which sustained release of both
insulinlike growth factor I and albumin marks preservation of
differentiated status. In contrast, transcripts of IGFBP-3 and IGFBP-2 were
not detected. Release of IGFBP-1 was unaffected by exposure to glucose
(20-500 mg/dl) or to provision of amino acids (0.25-6.25 times normal rat
arterial plasma levels). Hormonal studies revealed little effect of
glucagon, inhibition by insulin, stimulation by dexamethasone, and blunting
of dexamethasone effects by added insulin. Adding dexamethasone provided
progressive stimulation: 5-, 11-, and 26-fold at 10(-9), 10(-8), and 10(-7)
M, all P less than 0.01; increases in IGFBP-1 protein (ligand blot) and
IGFBP-1 mRNA (Northern blot) were highly correlated (r = 0.62, P less than
0.001). In contrast, adding insulin resulted in progressive suppression of
both IGFBP-1 protein and IGFBP-1 mRNA, 43% at 10(-10) M, 74% at 10(-9) M,
and 83% (maximal) at 10(-8) M; ED50 of approximately 10(-10) M is within
the physiological range of insulin concentrations.(ABSTRACT TRUNCATED AT
250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Veldhuis, J. Frystyk, A. Iranmanesh, and H. Orskov
Testosterone and Estradiol Regulate Free Insulin-Like Growth Factor I (IGF-I), IGF Binding Protein 1 (IGFBP-1), and Dimeric IGF-I/IGFBP-1 Concentrations
J. Clin. Endocrinol. Metab.,
May 1, 2005;
90(5):
2941 - 2947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A L Pierce, H Fukada, and W W Dickhoff
Metabolic hormones modulate the effect of growth hormone (GH) on insulin-like growth factor-I (IGF-I) mRNA level in primary culture of salmon hepatocytes
J. Endocrinol.,
February 1, 2005;
184(2):
341 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Lang, R. A. Frost, E. Svanberg, and T. C. Vary
IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats
Am J Physiol Endocrinol Metab,
June 1, 2004;
286(6):
E916 - E926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. El Khattabi, F. Gregoire, C. Remacle, and B. Reusens
Isocaloric maternal low-protein diet alters IGF-I, IGFBPs, and hepatocyte proliferation in the fetal rat
Am J Physiol Endocrinol Metab,
November 1, 2003;
285(5):
E991 - E1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Lang, T. C. Vary, and R. A. Frost
Acute in Vivo Elevation of Insulin-Like Growth Factor (IGF) Binding Protein-1 Decreases Plasma Free IGF-I and Muscle Protein Synthesis
Endocrinology,
September 1, 2003;
144(9):
3922 - 3933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sakai, H. B. Lowman, and D. R. Clemmons
Increases in Free, Unbound Insulin-like Growth Factor I Enhance Insulin Responsiveness in Human Hepatoma G2 Cells in Culture
J. Biol. Chem.,
April 12, 2002;
277(16):
13620 - 13627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koutsilieris, C. Mitsiades, T. Dimopoulos, A. Ioannidis, A. Ntounis, and T. Lambou
A Combination Therapy of Dexamethasone and Somatostatin Analog Reintroduces Objective Clinical Responses to LHRH Analog in Androgen Ablation-Refractory Prostate Cancer Patients
J. Clin. Endocrinol. Metab.,
December 1, 2001;
86(12):
5729 - 5736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J-G Scharf, F Dombrowski, and G Ramadori
The IGF axis and hepatocarcinogenesis
Mol. Pathol.,
June 1, 2001;
54(3):
138 - 144.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. M. Zimmermann, L. Li, E. C. Hoyt, J. B. Pucilowska, S. Lichtman, and P. K. Lund
Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver
Am J Physiol Gastrointest Liver Physiol,
March 1, 2000;
278(3):
G447 - G457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. G. Nyomba, L. Berard, and L. J. Murphy
Free Insulin-Like Growth Factor I (IGF-I) in Healthy Subjects: Relationship with IGF-Binding Proteins and Insulin Sensitivity
J. Clin. Endocrinol. Metab.,
July 1, 1997;
82(7):
2177 - 2181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thrailkill, T. Quattrin, L. Baker, J. Litton, K. Dwigun, M. Rearson, M. Poppenheimer, D. Kotlovker, D. Giltinan, N. Gesundheit, et al.
Dual Hormonal Replacement Therapy with Insulin and Recombinant Human Insulin-Like Growth Factor (IGF)-I in Insulin-Dependent Diabetes Mellitus: Effects on the Growth Hormone/IGF/IGF-Binding Protein System
J. Clin. Endocrinol. Metab.,
April 1, 1997;
82(4):
1181 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1992 by the American Diabetes Association.
|
|
| |
|